A detailed history of Ropes Wealth Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 44,337 shares of BMY stock, worth $2.52 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
44,337
Previous 53,280 16.78%
Holding current value
$2.52 Million
Previous $3.41 Million 24.48%
% of portfolio
0.5%
Previous 0.57%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$57.89 - $64.73 $517,710 - $578,880
-8,943 Reduced 16.78%
44,337 $2.57 Million
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $93,717 - $104,058
1,471 Added 2.84%
53,280 $3.41 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $54,079 - $61,338
823 Added 1.61%
51,809 $3.59 Million
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $132,645 - $157,071
-1,937 Reduced 3.66%
50,986 $3.67 Million
Q3 2022

Nov 01, 2022

SELL
$0.13 - $76.84 $1 - $998
-13 Reduced 0.02%
52,923 $3.76 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $66,810 - $73,581
-920 Reduced 1.71%
52,936 $4.08 Million
Q1 2022

May 04, 2022

SELL
$61.48 - $73.72 $154,068 - $184,742
-2,506 Reduced 4.45%
53,856 $3.93 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $545,577 - $636,015
-10,173 Reduced 15.29%
56,362 $3.51 Million
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $201,000 - $235,446
-3,397 Reduced 4.86%
66,535 $3.94 Million
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $173,905 - $189,382
2,809 Added 4.18%
69,932 $4.67 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $306,313 - $344,511
-5,162 Reduced 7.14%
67,123 $4.31 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $484,149 - $548,630
8,385 Added 13.12%
72,285 $4.48 Million
Q3 2020

Oct 16, 2020

BUY
$57.43 - $63.64 $36,870 - $40,856
642 Added 1.01%
63,900 $3.85 Million
Q2 2020

Jul 20, 2020

SELL
$54.82 - $64.09 $108,872 - $127,282
-1,986 Reduced 3.04%
63,258 $3.72 Million
Q1 2020

Apr 24, 2020

SELL
$46.4 - $67.43 $116,649 - $169,519
-2,514 Reduced 3.71%
65,244 $3.64 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $63,431 - $82,740
1,289 Added 1.94%
67,758 $4.35 Million
Q3 2019

Nov 05, 2019

SELL
$42.77 - $50.71 $90,330 - $107,099
-2,112 Reduced 3.08%
66,469 $3.37 Million
Q2 2019

Jul 31, 2019

SELL
$44.62 - $49.34 $16,152 - $17,861
-362 Reduced 0.53%
68,581 $3.11 Million
Q1 2019

Apr 15, 2019

BUY
$45.12 - $53.8 $48,955 - $58,373
1,085 Added 1.6%
68,943 $3.29 Million
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $8,240 - $10,685
169 Added 0.25%
67,858 $3.53 Million
Q3 2018

Oct 30, 2018

BUY
$55.19 - $62.25 $85,710 - $96,674
1,553 Added 2.35%
67,689 $4.2 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $231,326 - $288,322
4,578 Added 7.44%
66,136 $3.66 Million
Q1 2018

Apr 30, 2018

BUY
$59.92 - $68.98 $83,888 - $96,572
1,400 Added 2.33%
61,558 $3.89 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $201,758 - $219,968
-3,366 Reduced 5.3%
60,158 $3.69 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $3.51 Million - $4.05 Million
63,524
63,524 $4.05 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.